Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Analytical Chemistry >  Standard >  Pharmaceutical Impurity Reference Standards >  4-Methyl Erlotinib Hydrochloride

4-Methyl Erlotinib Hydrochloride

Basic information Safety Supplier Related

4-Methyl Erlotinib Hydrochloride Basic information

Product Name:
4-Methyl Erlotinib Hydrochloride
Synonyms:
  • N-[(3-Ethynyl-4-Methyl)phenyl]-6,7-bis(2-Methoxyethoxy)-4-quinazolinaMine Hydrochloride
  • OSI-597
  • Erlotinib iMpurity G
  • N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride
  • 4-Methyl Erlotinib Hydrochloride
  • N-(3-ETHYNYL-4-METHYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE HCL
  • 4-methyl Erlotinib
  • Erlotinib 4-Methyl Analog
CAS:
1346601-52-2
MF:
C23H25N3O4
MW:
407.46
Product Categories:
  • Amines
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
1346601-52-2.mol
More
Less

4-Methyl Erlotinib Hydrochloride Chemical Properties

Melting point:
224-228°C (dec.)
Boiling point:
567.5±50.0 °C(Predicted)
Density 
1.23±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer
solubility 
Chloroform (Slightly), DMSO, Methanol (Slightly)
pka
5.33±0.30(Predicted)
form 
Solid
color 
Pale Pink to Pale Brown
More
Less

4-Methyl Erlotinib Hydrochloride Usage And Synthesis

Uses

Erlotinib (E625000) derivative as internal standard for HPLC.

Biological Activity

4-methyl erlotinib is an analog of erlotinib by the addition of a methyl group at the four position of the phenyl group. erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (egfr) [1].the epidermal growth factor receptor (egfr) autocrine pathway has been important for cancer development and progression, including cell proliferation, apoptosis, angiogenesis, and metastatic spread [2].erlotinib inhibits egfr-associated kinase activity by binding to the egf-activated receptor, with the phenyl group at one end sequestered in a hydrophobic pocket of the kinase domain and the ether linkages at the opposite end projecting into solvent [1].erlotinib can prolong survival in patients with non–small-cell lung cancer after first-line or second-line chemotherapy [3].

References

[1] stamos, j. ,sliwkowski, m.x. and eigenbrot, c. structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. the journal of biological chemisty 277(48), 46265-46272 (2002).
[2] ciardiello f, tortora g. a novel approach in the treatment of cancer: targeting the epidermal growth factor receptor[j]. clinical cancer research, 2001, 7(10): 2958-2970.
[3] shepherd f a, rodrigues pereira j, ciuleanu t, et al. erlotinib in previously treated non–small-cell lung cancer[j]. new england journal of medicine, 2005, 353(2): 123-132.

4-Methyl Erlotinib HydrochlorideSupplier

Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Beijing Comparison Pharmaceutical Technology Co., Ltd
Tel
010-010-52878169 15801002657
Email
sales@bjcomparison.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Email
sales@reading-chemicals.com
Chengdu Miracle Pharmaceutical Co., Ltd.
Tel
028-86136736 19130631884
Email
sales@mic-pharma.com
XinYao(Shenzhen) Biological Technology Co., Ltd.
Tel
0755-89880280
Email
3004662104@qq.com